As CDK8 is amplified and functions as an oncogene in colorectal cancer through the regulation of Wnt/β-catenin signaling [17, 18, 37], the therapeutic potential of the small molecules has been actively tested in preclinical models of colorectal and other cancers [19, 36]. This evidence concerns the gene CDK8 and colorectal cancer.